| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, COATED / ORAL | NA | | Exact identifier — unii+route 44 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, FILM COATED / ORAL | 2.5 mg | | Exact identifier — unii+route 44 equally ranked IID candidates |
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | SOLUTION / ORAL | 50 mg/5ml | | Exact identifier — unii+route 14 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, EXTENDED RELEASE / ORAL | 335.1 mg | | Exact identifier — unii+route 40 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | DROPS / ORAL | NA | | Exact identifier — unii+route 44 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | POWDER, FOR SOLUTION / ORAL | 0.33 mg/5ml | | Exact identifier — unii+route 44 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | | 12 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION/ DROPS / ORAL | | 23 mg | Exact identifier — unii+route 38 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / ORAL | | 660 mg | Exact identifier — unii+route 38 equally ranked IID candidates |
| D&C RED NO. 33 | D&C RED NO. 33 | 9DBA0SBB0L | SOLUTION / ORAL | | 2 mg | Exact identifier — unii+route 24 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / SUBCUTANEOUS | 0.7 %w/v | | Exact identifier — unii+dosage form 40 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EFFERVESCENT / ORAL | | 840 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | PASTE / ORAL | | 26 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, DELAYED RELEASE / ORAL | 0.34 mg | | Exact identifier — unii+route 38 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | | Exact identifier — unii+route 38 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | | 2400 mg | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | | Exact identifier — unii+route 38 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, COATED / ORAL | 0.2 mg | | Exact identifier — unii+route 38 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, COATED / ORAL | 54.7 mg | | Exact identifier — unii+route 40 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, FOR SUSPENSION / ORAL | | 120 mg | Exact identifier — unii+route 38 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ORAL | | 98 mg | Exact identifier — unii+route 40 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CONCENTRATE / ORAL | | 20 mg | Exact identifier — unii+route 38 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, EXTENDED RELEASE / ORAL | NA | | Exact identifier — unii+route 38 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / ORAL | | 400 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SYRUP / ORAL | | 268 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / ORAL | NA | | Exact identifier — unii+route 40 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE / ORAL | | 16 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| D&C RED NO. 33 | D&C RED NO. 33 | 9DBA0SBB0L | CAPSULE, LIQUID FILLED / ORAL | 0.01 mg | | Exact identifier — unii+route 24 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | ELIXIR / ORAL | 1 mg | | Exact identifier — unii+route 40 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET / ORAL | | 231 mg | Exact identifier — unii+route 40 equally ranked IID candidates |
| D&C RED NO. 33 | D&C RED NO. 33 | 9DBA0SBB0L | SUSPENSION, EXTENDED RELEASE / ORAL | NA | | Exact identifier — unii+route 24 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, COATED PELLETS / ORAL | NA | | Exact identifier — unii+route 44 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION, EXTENDED RELEASE / ORAL | | 62 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, DELAYED RELEASE / ORAL | | 2 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, DELAYED RELEASE / ORAL | | 5 mg | Exact identifier — unii+route 14 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | POWDER, FOR SUSPENSION / ORAL | | 3 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CONCENTRATE / ORAL | 0.04 mg/1ml | | Exact identifier — unii+route 44 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EXTENDED RELEASE / ORAL | | 312 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, LIQUID FILLED / ORAL | | 1 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| D&C RED NO. 33 | D&C RED NO. 33 | 9DBA0SBB0L | CONCENTRATE / ORAL | 0.02 mg/1ml | | Exact identifier — unii+route 24 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | | Exact identifier — unii+route 44 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, FILM COATED / ORAL | | 100 mg | Exact identifier — unii+route 40 equally ranked IID candidates |
| D&C RED NO. 33 | D&C RED NO. 33 | 9DBA0SBB0L | SUSPENSION, EXTENDED RELEASE / ORAL | NA | | Exact identifier — unii+route 24 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | SUSPENSION/ DROPS / ORAL | | 1 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | SUSPENSION / ORAL | 100 mg/5ml | | Exact identifier — unii+route 44 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, FILM COATED / ORAL | | 1 mg | Exact identifier — unii+route 38 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | CAPSULE / ORAL | | 6 mg | Exact identifier — unii+route 40 equally ranked IID candidates |
| D&C RED NO. 33 | D&C RED NO. 33 | 9DBA0SBB0L | TABLET / ORAL | 0.24 mg | | Exact identifier — unii+route 24 equally ranked IID candidates |
| D&C RED NO. 33 | D&C RED NO. 33 | 9DBA0SBB0L | CAPSULE, LIQUID FILLED / ORAL | 0.01 mg | | Exact identifier — unii+route 24 equally ranked IID candidates |
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, EXTENDED RELEASE / ORAL | | 40 mg | Exact identifier — unii+route 14 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, CHEWABLE / ORAL | | 20 mg | Exact identifier — unii+route 40 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | POWDER, FOR SOLUTION / ORAL | 0.33 mg/5ml | | Exact identifier — unii+route 44 equally ranked IID candidates |
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | POWDER, FOR SUSPENSION / ORAL | 0.01 mg | | Exact identifier — unii+route 14 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE / ORAL | | 131 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | | 48 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM, SOLUBLE / ORAL | | 7 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EFFERVESCENT / ORAL | | 840 mg | Exact identifier — unii+route 44 equally ranked IID candidates |
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | SOLUTION / ORAL | 50 mg/5ml | | Exact identifier — unii+route 14 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | | Exact identifier — unii+route 44 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 0.02 mg | | Exact identifier — unii+route 44 equally ranked IID candidates |